These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The company Light Horse Therapeutics, which launched after the tournament ended, leverages genome editing to find oncology targets that a small molecule could act on. Its name evokes a majestic ...

In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

The US Department of Agriculture (USDA; Washington, DC) has announced the appointment of an advisory committee on agricultural biotechnology. Although some will see this as a response to growing ...

Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...